Trading Window

Date: 27th September, 2026 Listing Department, National Stock Exchange of India Limited Exchange Plaza, Plot No C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400051 Ref: NSE Symbol: BALAXI Dear Sir/Madam, Sub: Intimation of Closure of Trading Window Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Internal Procedures and Conduct to regulate, monitor and report trading by Insiders, the trading window for dealing in securities of the Company for all the Designated Persons and their Immediate Relatives will remain closed from October 01, 2026 till conclusion of 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter and half year ending 30th September, 2026. The date of the meeting of Board of Directors for the consideration and approval of the Unaudited Financial Results of the Company for the quarter and half year ending 30th September, 2026 will be informed in due course. This is for your information and records. Thanking You. For Balaxi Pharmaceuticals Limited Aman Purohit (Company Secretary & Compliance Officer) ICSI Membership No.: A59345